US 8609716
Chondropsin-class antitumor V-ATPase inhibitor compounds, compositions and methods of use thereof
granted A61PA61P13/00A61P15/08
Quick answer
US patent 8609716 (Chondropsin-class antitumor V-ATPase inhibitor compounds, compositions and methods of use thereof) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Dec 12 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America, as represented by the Secretary, Department of Health and Human Services
- Grant date
- Tue Dec 17 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Dec 12 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 10
- CPC classes
- A61P, A61P13/00, A61P15/08, A61P19/08, A61P19/10